Department of Vascular and Endovascular Surgery, University Hospital Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
Langenbecks Arch Surg. 2024 Nov 12;409(1):345. doi: 10.1007/s00423-024-03523-5.
Because of the lack of specific recommendations concerning cardiac risk stratification before vascular surgery, appropriate decisions remain individual. The aim of the present study was to evaluate the perioperative cardiac management in vascular surgery in Germany.
This article is based on a survey from 2018 of heads of German vascular surgical departments or units regarding their experience with perioperative cardiac management. The questionnaire asked about the experience with preoperative cardiac evaluation and its extension, awareness of perioperative myocardial ischemia, the art of postoperative monitoring and the routine use of the best medical treatment.
In total, 62% of responders agreed that perioperative myocardial ischemia is a relevant postoperative problem in their clinic after open abdominal aortic surgery, while 47% stated the same after vascular surgery (VS) like carotid endarterectomy, peripheral arterial surgery or EVAR. Preoperative cardiological evaluations are performed routinely by 87% of responders before open abdominal aortic surgery and by 42% before VS. Preoperative cardiac evaluation included cardiac echography in 92% and stress diagnostics (stress echography, stress ECG) in 38%. Routine preoperative cardiac catheterisation is performed in 4% before OAS and only 0.5% before VS. In addition, 79% of participants initiate acetylsalicylic acid routinely and 68% use statins preoperatively. The serum troponin diagnostic test in asymptomatic patients was routinely applied by 19% of responders after OAS and by 6% after VS.
Perioperative myocardial ischemia is considered a relevant problem, primarily after aortic surgery. The preoperative cardiac stress diagnostics among vascular surgeons does not seem to be sufficiently widespread. The preoperative initiation of acetylsalicylic acid and statins is not routine in 30% of hospitals.
由于血管外科术前缺乏特定的心脏风险分层建议,因此仍需个体化决策。本研究旨在评估德国血管外科围手术期的心脏管理。
本文基于 2018 年对德国血管外科部门负责人的调查,了解他们在围手术期心脏管理方面的经验。调查问卷询问了术前心脏评估及其扩展、围术期心肌缺血意识、术后监测方法以及最佳药物治疗的常规使用等问题。
共有 62%的受访者认为开放性腹主动脉手术后其诊所存在相关的术后心肌缺血问题,而 47%的受访者在颈动脉内膜切除术、外周动脉手术或 EVAR 等血管手术后也认为存在相关问题。87%的受访者在开放性腹主动脉手术前常规进行心脏评估,42%的受访者在血管手术后进行。术前心脏评估包括 92%的心脏超声检查和 38%的应激诊断(应激超声心动图、应激心电图)。4%的受访者在 OAS 前常规进行术前心脏导管检查,而只有 0.5%的受访者在 VS 前进行。此外,79%的参与者常规使用阿司匹林,68%的人术前使用他汀类药物。19%的受访者在 OAS 后、6%的受访者在 VS 后常规进行无症状患者的血清肌钙蛋白诊断检测。
围手术期心肌缺血被认为是一个重要问题,主要发生在主动脉手术后。血管外科医生的术前心脏应激诊断似乎还不够广泛。30%的医院并未常规开始使用阿司匹林和他汀类药物。